# Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

> **NCT07292519** · PHASE2 · NOT_YET_RECRUITING · sponsor: **South West Sydney Local Health District** · enrollment: 46 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)
- Overweight or Obese
- Comorbidities and Coexisting Conditions

## Interventions

- **DRUG:** Tirzepatide
- **BEHAVIORAL:** Take Control CBT Module
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07292519
- **Lead sponsor:** South West Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-05-15
- **Final completion:** 2028-01-15
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07292519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07292519, "Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07292519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
